These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10361162)

  • 1. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.
    Brand RM; Hamel FG
    Int J Pharm; 1999 Jun; 183(2):117-23. PubMed ID: 10361162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of iontophoresis and the chelating agent 1,10 phenanthroline act synergistically as penetration enhancers.
    Brand RM; Hannah TL; Hamel FG
    AAPS PharmSci; 2000; 2(4):E35. PubMed ID: 11741251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel system to study the impact of epithelial barriers on cellular metabolism.
    Brand RM; Hannah TL; Mueller C; Cetin Y; Hamel FG
    Ann Biomed Eng; 2000; 28(10):1210-7. PubMed ID: 11144982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pulse current iontophoretic transdermal delivery of insulin on blood glucose in diabetic rats].
    Mao XM; Liang BW; Yao YP; Fang SZ; Li Q
    Yao Xue Xue Bao; 1995 Dec; 30(12):881-5. PubMed ID: 8712012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential acute effects of oxovanadiums and insulin on glucose and lactate metabolism under in vivo and in vitro conditions.
    Liu J; Reuland DJ; Rosenhein L; Cao ZX; Franklin LA; Ganguli S
    Metabolism; 1997 May; 46(5):562-72. PubMed ID: 9160825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peroxovanadium compound stimulates muscle glucose transport as powerfully as insulin and contractions combined.
    Nolte LA; Han DH; Hansen PA; Hucker KA; Holloszy JO
    Diabetes; 2003 Aug; 52(8):1918-25. PubMed ID: 12882906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
    Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
    J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
    Westergaard N; Brand CL; Lewinsky RH; Andersen HS; Carr RD; Burchell A; Lundgren K
    Arch Biochem Biophys; 1999 Jun; 366(1):55-60. PubMed ID: 10334863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats.
    King MJ; Badea I; Solomon J; Kumar P; Gaspar KJ; Foldvari M
    Diabetes Technol Ther; 2002; 4(4):479-88. PubMed ID: 12396742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
    Becker DJ; Ongemba LN; Henquin JC
    Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
    Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement.
    Zakzewski CA; Wasilewski J; Cawley P; Ford W
    J Control Release; 1998 Jan; 50(1-3):267-72. PubMed ID: 9685893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
    Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
    J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used.
    Domingo JL; Gomez M; Llobet JM; Corbella J; Keen CL
    Toxicology; 1991 Mar; 66(3):279-87. PubMed ID: 1826377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of peroxovanadium compounds in BB rats.
    Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.